Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Normalization of circulating plasma levels of miRNAs in HIV-1/HCV co-infected patients following direct-acting antiviral-induced sustained virologic response.
Rapid and accurate quantification of isomiRs by RT-qPCR.
Circulating MicroRNAs as a Tool for Diagnosis of Liver Disease Progression in People Living with HIV-1.
Reducing HIV-1 env gene CpG frequency increases the replication capacity of the HXB2 virus strain.
Efficacy of repurposed antiviral drugs: lessons from COVID-19.
What Should Be Learned From Repurposed Antivirals Against SARS-CoV-2?
Circulating microRNA signatures that predict liver fibrosis progression in patients with HIV-1/HCV co-infections.
Single nucleotide polymorphisms in PNPLA3, ADAR-1, and IFIH1 are associated with advanced liver fibrosis in patients co-infected with HIV-1/HCV.
Plitidepsin: a repurposed drug for the treatment of COVID-19.
Gene Affects Virus Replication Capacity.